The Bangalore-based Healthcare Global (HCG) is gearing up for its overseas debut even while negotiating with a few private equity players to close its fourth round of funding. The oncology major is in advanced talks with PEs including a US-based one, to raise Rs 50 crore. So far, the Rs 110-crore specialised healthcare operator has raised about Rs 50 crore from IDFC Private Equity, Evolence India Life Sciences Fund and PremjiInvest. This time around, India Venture Advisors, the Piramal-group healthcare focused private equity fund is also in the fray. Having made considerable headway in its talks with HCG, it is ready to infuse Rs 60 crore. However, further details on the deal are not available. […]